A family history of pancreatic cancer is reported in about 5%–10% of newly diagnosed cases (66–68) with germline mutations in BRCA2 contributing to approximately 6%–17% of these cases (14, 66, 69) (Table 1). Here, BRCA2 is linked to pancreatic neoplasm.